Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

Pharmaceutical Strategies Group (“PSG”), an EPIC company, published its 2025 Trends in Drug Benefit Design Report, delivering critical insights into how payers are navigating a rapidly ...

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

State legislatures, including Oregon, have tried to level the playing field for pharmacies. Mayo said reform efforts in Oregon have focused on requiring pharmacy benefit managers to pay dispensing ...

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...

Since 2005, the cost of health care has increased an average of 6% each year, and the burden falls on both employers and ...

In other countries, the government negotiates with pharmaceutical companies directly to set a single market price. In the U.S ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...